On this page
Follistim
follitropin beta
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Follistim
Proper name
follitropin beta
Licence type
351(a)
BLA number
020582
Applicant
Organon USA Inc., a subsidiary of Merck & Co., Inc.
Center
CDER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 150IU | For Injection | Subcutaneous, Intramuscular | Single-Dose Vial | Disc | September 29, 1997 |
| 75IU | For Injection | Subcutaneous, Intramuscular | Single-Dose Vial | Disc | September 29, 1997 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |